Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
88.10    0.90 (1.03%)
Bid:
87.30
Ask:
88.50
Spread: 1.20 (1.375%)
Market Cap: £370.33m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

AGM Trading Statement

22 Sep 2015 07:00

RNS Number : 7275Z
PZ CUSSONS PLC
22 September 2015
 



PZ Cussons Plc

(the "Group")

 

AGM Trading Statement

 

PZ Cussons Plc, a leading international consumer products group, today issues the following trading update which covers the period 1 June 2015 to 21 September 2015, in advance of its Annual General Meeting, to be held at 10:30 today.

 

Overview of financial performance and position

 

The board is pleased to announce that the performance of the Group during the period has been in line with expectations. The financial position of the Group remains strong with cash generation during the period also in line with expectations. We are pleased with the impact of our product launches and our innovative product pipeline which are helping the business make progress in challenging markets.

 

Trading Update

 

Europe

 

In the UK, performance in the washing and bathing division has been strongly driven by an exciting innovation pipeline and the launch of a brand new range of Carex bodywash products.

 

The beauty division has performed well across its key markets with St Tropez's new gradual tan in shower lotion performing particularly well. The Sanctuary brand has also performed well supported by a new #LetGO campaign.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In all Asian markets, a further weakening in exchange rates is increasing local costs, reducing consumer disposable income and reducing results on translation to sterling.

 

In Australia there has been a modest improvement in the homecare trading environment with good progress made across personal care, beauty and the food & nutrition brands Rafferty's Garden and five:am.

 

In Indonesia, revenue growth has continued to be strong despite the more challenging consumer environment as a result of slower GDP growth and a weaker exchange rate.

 

Performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

 

Africa

 

In Nigeria, the exchange rate has remained stable against the dollar although low oil prices continue to contribute to an environment of tight liquidity with additional foreign exchange restrictions imposed for certain imported items. Despite this, good performances across personal care, home care and food & nutrition are offsetting the more difficult trading environment for discretionary bigger ticket electrical items.

 

The underlying performance in the smaller markets of Ghana and Kenya has been in line with expectations, however weaker exchange rates have impacted reported results.

 

Outlook

 

Ongoing challenges relate principally to weakening exchange rates, particularly in Australia, Indonesia and Nigeria where imported inflation is affecting margins as well as consumer disposable income. In Nigeria, the tightening in foreign currency rules is also restricting dollar availability for certain items.

 

The strength of the Group's new product pipeline and the success of recent product launches leave the Group well placed to counter these challenges.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

A further trading update will be made on 10 December 2015.

 

Enquiries:

 

PZ Cussons Plc

Brandon Leigh Tel: 0161 435 1236

 

Instinctif

Tim Linacre / Guy Scarborough Tel: 020 7457 2020

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMQFLFLEKFBBBV
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.